Larimar Therapeutics Inc.

NASDAQ: LRMR · Real-Time Price · USD
2.46
0.01 (0.41%)
At close: Jun 05, 2025, 3:59 PM
2.41
-1.76%
After-hours: Jun 05, 2025, 06:23 PM EDT

Larimar Therapeutics Statistics

Share Statistics

Larimar Therapeutics has 64.03M shares outstanding. The number of shares has increased by 0.35% in one year.

64.03M
0.35%
0.35%
99.41%
n/a
331
0.03%

Short Selling Information

The latest short interest is 9.83M, so 15.36% of the outstanding shares have been sold short.

9.83M
15.36%
27.8%
6.1

Valuation Ratios

The PE ratio is -2.94 and the forward PE ratio is -1.24. Larimar Therapeutics's PEG ratio is -0.05.

-2.94
-1.24
0
0.4
1.38
-3.33
-0.05
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Larimar Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 8.02, with a Debt / Equity ratio of 0.03.

8.02
8.02
0.03
-0.06
-0.07
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1,240,061.54
65
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -74.11% in the last 52 weeks. The beta is 0.79, so Larimar Therapeutics's price volatility has been higher than the market average.

0.79
-74.11%
2.14
4.66
59.79
1,141,090

Income Statement

n/a
n/a
-90.89M
-80.6M
-80.29M
n/a
-1.32
Full Income Statement

Balance Sheet

The company has 33.22M in cash and 5.12M in debt, giving a net cash position of 28.1M.

33.22M
5.12M
28.1M
-269.16M
170.18M
143.35M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -70.76M and capital expenditures -515K, giving a free cash flow of -71.28M.

-70.76M
-515K
-71.28M
-1.16
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

LRMR does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for LRMR is $18, which is 631.7% higher than the current price. The consensus rating is "Buy".

$18
631.7%
Buy
7
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on May 29, 2020. It was a backward split with a ratio of 1:12.

May 29, 2020
backward
1:12

Scores

-0.3
3